Boris Peaker
Stock Analyst at TD Cowen
(2.13)
# 1,524
Out of 4,412 analysts
20
Total ratings
23.08%
Success rate
5.14%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALPN Alpine Immune Sciences | Downgrades: Hold | n/a | $64.62 | - | 1 | Apr 16, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | n/a | $14.37 | - | 2 | Apr 9, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $65.20 | +53.37% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $4.44 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $25.50 | +96.08% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $60.06 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $19.23 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $1.95 | +1,387.18% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $1.60 | - | 1 | Jul 11, 2022 | |
| MRK Merck & Co. | Maintains: Market Perform | $95 → $102 | $130.72 | -21.97% | 1 | Jun 27, 2022 | |
| NKTR Nektar Therapeutics | Downgrades: Market Perform | n/a | $1.32 | - | 1 | Mar 15, 2022 | |
| NCNA NuCana | Downgrades: Market Perform | n/a | $3.81 | - | 1 | Mar 3, 2022 | |
| AADI Aadi Bioscience | Initiates: Outperform | n/a | $1.68 | - | 1 | Oct 1, 2021 | |
| TCRX TScan Therapeutics | Initiates: Outperform | n/a | $7.29 | - | 1 | Aug 13, 2021 | |
| CELC Celcuity | Initiates: Outperform | n/a | $15.77 | - | 1 | Jul 29, 2021 | |
| FUSN Fusion Pharmaceuticals | Initiates: Outperform | n/a | $21.40 | - | 1 | Jul 21, 2020 | |
| STRO Sutro Biopharma | Initiates: Outperform | n/a | $3.42 | - | 1 | Oct 22, 2018 | |
| MRSN Mersana Therapeutics | Initiates: Outperform | n/a | $2.85 | - | 1 | Jul 24, 2017 | |
| ARGX argenx SE | Initiates: Outperform | n/a | $368.60 | - | 1 | Jun 12, 2017 |
Alpine Immune Sciences
Apr 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $64.62
Upside: -
MacroGenics
Apr 9, 2024
Upgrades: Buy
Price Target: n/a
Current: $14.37
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $65.20
Upside: +53.37%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.44
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $25.50
Upside: +96.08%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $60.06
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $19.23
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $1.95
Upside: +1,387.18%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.60
Upside: -
Merck & Co.
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $130.72
Upside: -21.97%
Nektar Therapeutics
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.32
Upside: -
NuCana
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $3.81
Upside: -
Aadi Bioscience
Oct 1, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.68
Upside: -
TScan Therapeutics
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.29
Upside: -
Celcuity
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $15.77
Upside: -
Fusion Pharmaceuticals
Jul 21, 2020
Initiates: Outperform
Price Target: n/a
Current: $21.40
Upside: -
Sutro Biopharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.42
Upside: -
Mersana Therapeutics
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $2.85
Upside: -
argenx SE
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $368.60
Upside: -